Chitosan oligosaccharide decorated liposomes combined with TH302 for photodynamic therapy in triple negative breast cancer
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Chitosan oligosaccharide decorated liposomes combined with TH302 for photodynamic therapy in triple negative breast cancer
Authors
Keywords
-
Journal
JOURNAL OF NANOBIOTECHNOLOGY
Volume 19, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-05-19
DOI
10.1186/s12951-021-00891-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Newly Developed Prodrugs and Prodrugs in Development; an Insight of the Recent Years
- (2020) Anas Najjar et al. MOLECULES
- Progress in triple negative breast carcinoma pathophysiology: Potential therapeutic targets
- (2020) Kangjie Yu et al. PATHOLOGY RESEARCH AND PRACTICE
- Expanding the Role for Immunotherapy in Triple-Negative Breast Cancer
- (2020) Peter Savas et al. CANCER CELL
- Role of Immunotherapy in Triple-Negative Breast Cancer
- (2020) Tanya E. Keenan et al. Journal of the National Comprehensive Cancer Network
- Triple-Negative Breast Cancer: A Review of Conventional and Advanced Therapeutic Strategies
- (2020) Mauricio A. Medina et al. International Journal of Environmental Research and Public Health
- Nanoscale Metal–Organic Frameworks Generate Reactive Oxygen Species for Cancer Therapy
- (2020) Kaiyuan Ni et al. ACS Central Science
- Molecular subtypes and precision treatment of triple-negative breast cancer
- (2020) Shen Zhao et al. Annals of Translational Medicine
- Development of a new photosafety test method based on singlet oxygen generation detected using electron spin resonance
- (2020) Masumi Hinoshita et al. JOURNAL OF APPLIED TOXICOLOGY
- A multifunctional magnetic nanosystem based on “two strikes” effect for synergistic anticancer therapy in triple-negative breast cancer
- (2020) Yu Zhang et al. JOURNAL OF CONTROLLED RELEASE
- Akt-targeted therapy as a promising strategy to overcome drug resistance in breast cancer – A comprehensive review from chemotherapy to immunotherapy
- (2020) Parham Jabbarzadeh Kaboli et al. PHARMACOLOGICAL RESEARCH
- Co-delivery of IKBKE siRNA and cabazitaxel by hybrid nanocomplex inhibits invasiveness and growth of triple-negative breast cancer
- (2020) Zhen Zhao et al. Science Advances
- The Synthesis of Nano-Doxorubicin and its Anticancer Effect.
- (2020) Lusha Zhu et al. Anti-Cancer Agents in Medicinal Chemistry
- Chinese Herbal Medicine for Reducing Chemotherapy-Associated Side-Effects in Breast Cancer Patients: A Systematic Review and Meta-Analysis
- (2020) Sha Li et al. Frontiers in Oncology
- Cancer statistics, 2019
- (2019) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Clinical efficacy and safety of paclitaxel liposomes as first-line chemotherapy in advanced gastric cancer
- (2019) Guangjie Han et al. Future Oncology
- Impact of Tumour Hypoxia on Evofosfamide Sensitivity in Head and Neck Squamous Cell Carcinoma Patient-Derived Xenograft Models
- (2019) Julia K. Harms et al. Cells
- Evofosfamide sensitizes esophageal carcinomas to radiation without increasing normal tissue toxicity
- (2019) Linda Spiegelberg et al. RADIOTHERAPY AND ONCOLOGY
- Insight into the efficiency of oxygen introduced photodynamic therapy (PDT) and deep PDT against cancers with various assembled nanocarriers
- (2019) Jie Zhao et al. Wiley Interdisciplinary Reviews-Nanomedicine and Nanobiotechnology
- Targeting immune pathways in breast cancer: review of the prognostic utility of TILs in early stage triple negative breast cancer (TNBC)
- (2019) Elizabeth F Blackley et al. BREAST
- The Course of Immune Stimulation by Photodynamic Therapy: Bridging Fundamentals of Photochemically Induced Immunogenic Cell Death to the Enrichment of T‐Cell Repertoire
- (2019) Shubhankar Nath et al. PHOTOCHEMISTRY AND PHOTOBIOLOGY
- Innovative Strategies for Hypoxic-Tumor Photodynamic Therapy
- (2018) Xingshu Li et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- cRGD Peptide-Conjugated Pyropheophorbide-a Photosensitizers for Tumor Targeting in Photodynamic Therapy
- (2018) Wenjing Li et al. MOLECULAR PHARMACEUTICS
- Carboplatin in BRCA1/2-mutated and triple-negative breast cancer BRCAness subgroups: the TNT Trial
- (2018) Andrew Tutt et al. NATURE MEDICINE
- In vivo wireless photonic photodynamic therapy
- (2018) Akshaya Bansal et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The timeliness of patients reporting the side effects of chemotherapy
- (2018) Ian Olver et al. SUPPORTIVE CARE IN CANCER
- Tumor Hypoxia As an Enhancer of Inflammation-Mediated Metastasis: Emerging Therapeutic Strategies
- (2018) Josh W. DiGiacomo et al. Targeted Oncology
- Metastatic and triple-negative breast cancer: challenges and treatment options
- (2018) Sumayah Al-Mahmood et al. Drug Delivery and Translational Research
- Radiotherapy in triple-negative breast cancer: Current situation and upcoming strategies
- (2018) Ming Yuan He et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Extensive preclinical investigation of polymersomal formulation of doxorubicin versus Doxil-mimic formulation
- (2017) Mona Alibolandi et al. JOURNAL OF CONTROLLED RELEASE
- Folic Acid–Conjugated Pyropheophorbide a as the Photosensitizer Tested for In Vivo Targeted Photodynamic Therapy
- (2017) Jin Wang et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Overcoming the Limits of Hypoxia in Photodynamic Therapy: A Carbonic Anhydrase IX-Targeted Approach
- (2017) Hyo Sung Jung et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Hypoxia-activated prodrug TH-302 decreased survival rate of canine lymphoma cells under hypoxic condition
- (2017) Hiroki Yamazaki et al. PLoS One
- Nanoceria-Mediated Drug Delivery for Targeted Photodynamic Therapy on Drug-Resistant Breast Cancer
- (2016) Hong Li et al. ACS Applied Materials & Interfaces
- Theranostic Liposomes with Hypoxia-Activated Prodrug to Effectively Destruct Hypoxic Tumors Post-Photodynamic Therapy
- (2016) Liangzhu Feng et al. ACS Nano
- Evofosfamide, a new horizon in the treatment of pancreatic cancer
- (2016) Mohsen Pourmorteza et al. ANTI-CANCER DRUGS
- Hypoxia: A Double-Edged Sword in Cancer Therapy
- (2016) Hamed Manoochehri Khoshinani et al. CANCER INVESTIGATION
- CD44: More than a mere stem cell marker
- (2016) I. Morath et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Phototheranostics of CD44-positive cell populations in triple negative breast cancer
- (2016) Jiefu Jin et al. Scientific Reports
- Chitosan-Decorated Doxorubicin-Encapsulated Nanoparticle Targets and Eliminates Tumor Reinitiating Cancer Stem-like Cells
- (2015) Wei Rao et al. ACS Nano
- Photodynamic therapy (PDT) using HPPH for the treatment of precancerous lesions associated with barrett's esophagus
- (2015) Hector R. Nava et al. LASERS IN SURGERY AND MEDICINE
- Correlation between epidermal growth factor receptor and tumor stem cell markers CD44/CD24 and their relationship with prognosis in breast invasive ductal carcinoma
- (2014) Zhousan Zheng et al. MEDICAL ONCOLOGY
- Breast cancer statistics, 2013
- (2013) Carol DeSantis et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Photodynamic therapy of cancer: An update
- (2011) Patrizia Agostinis et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Porphysome nanovesicles generated by porphyrin bilayers for use as multimodal biophotonic contrast agents
- (2011) Jonathan F. Lovell et al. NATURE MATERIALS
- Effect of molecular weight on the oleoyl-chitosan nanoparticles as carriers for doxorubicin
- (2010) Jing Zhang et al. COLLOIDS AND SURFACES B-BIOINTERFACES
- SPION-loaded chitosan–linoleic acid nanoparticles to target hepatocytes
- (2008) Chang-Moon Lee et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started